Hypofractionated radiotherapy with concurrent chemotherapy in locally advanced carcinoma cervix
- Conditions
- Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecifiedHealth Condition 2: C530- Malignant neoplasm of endocervixHealth Condition 3: C531- Malignant neoplasm of exocervix
- Registration Number
- CTRI/2024/03/064912
- Lead Sponsor
- AIIMS, New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Histopathologically confirmed squamous and adenosquamous carcinoma cervix patients, ECOG score of = 2, Clinical FIGO stage IB3 to IIIB, No or controlled comorbidities which may not compromise delivery of protocol defined chemotherapy and radiotherapy, Normal hematological and biochemical parameters, adequate cardiac function, informed written consent
ECOG score 3-4, Previous radiotherapy to abdomen or pelvis or previous chemotherapy, FIGO Stage IIIC1, IIIC2, IVA and IVB, Synchronous malignancy at any other site or any other malignancy in the past five years, Any uncontrolled comorbidity which may compromise delivery of protocol defined chemotherapy and radiotherapy, Connective tissue disorder, Ineligible to receive cisplatin
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method